Clinical Trial Update: Definitive Radiochemotherapy Plus/Minus Cetuximab in Unresectable Locally Advanced Esophageal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating definitive radiochemotherapy with or without cetuximab in unresectable locally advanced esophageal cancer has completed with pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer

Drugs mentioned

• Cetuximab (cetuximab)

Snippet

Sponsor: University Hospital Schleswig-Holstein | Conditions: Esophageal Cancer | Phase 2 | Status: COMPLETED | Results posted: 2020-03-10